| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
lactotransferrin | 0.543 | 0.846 | 1.3E-21 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
group | 0.160 | None | 0.833 | 6 | 2 | 2006 | 2018 | ||||||||
|
collagen type II alpha 1 chain | 0.444 | 0.846 | 1.00 |
|
group | 0.120 | None | 1.000 | 2 | 0 | 1999 | 2012 | ||||||||
|
proteoglycan 4 | 0.601 | 0.615 | 1.7E-08 |
|
group | 0.120 | None | 0.500 | 2 | 0 | 2017 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily V member 4 | 0.457 | 0.808 | 2.2E-16 |
|
group | 0.110 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ANKH inorganic pyrophosphate transport regulator | 0.606 | 0.692 | 0.28 |
|
group | 0.110 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 | 0.547 | 0.769 | 6.5E-13 |
|
group | 0.110 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
cellular communication network factor 6 | 0.568 | 0.731 | 6.2E-04 |
|
group | 0.110 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.110 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
group | 0.100 | None | 0.964 | 28 | 1 | 2004 | 2020 | ||||||||
|
hepcidin antimicrobial peptide | 0.433 | 0.846 | 8.2E-03 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
bone morphogenetic protein 2 | 0.432 | 0.846 | 0.99 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
carbohydrate sulfotransferase 3 | 0.517 | 0.846 | 7.2E-03 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
homogentisate 1,2-dioxygenase | 0.631 | 0.577 | 3.0E-08 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
matrix metallopeptidase 14 | 0.447 | 0.769 | 1.00 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
collagen type XI alpha 1 chain | 0.495 | 0.846 | 1.00 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
alkaline phosphatase, biomineralization associated | 0.546 | 0.769 | 3.6E-04 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
15-hydroxyprostaglandin dehydrogenase | 0.516 | 0.731 | 1.4E-05 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
atlastin GTPase 3 | 0.736 | 0.462 | 1.3E-09 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
hemojuvelin BMP co-receptor | 0.621 | 0.654 | 4.2E-03 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 2000 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 1995 | 2018 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 1993 | 2015 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1998 | 2019 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 1993 | 2017 |